| Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study L Staerk, GYH Lip, JB Olesen, EL Fosbøl, JL Pallisgaard, AN Bonde, ... Bmj 351, 2015 | 161 | 2015 |
| Risk of atrial fibrillation in diabetes mellitus: a nationwide cohort study JL Pallisgaard, AM Schjerning, TB Lindhardt, K Procida, ML Hansen, ... European journal of preventive cardiology 23 (6), 621-627, 2016 | 138 | 2016 |
| Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: temporal trends 2011–2015 in Denmark L Staerk, EL Fosbøl, K Gadsbøll, C Sindet-Pedersen, JL Pallisgaard, ... Scientific reports 6 (1), 31477, 2016 | 102 | 2016 |
| Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study JL Pallisgaard, GH Gislason, J Hansen, A Johannessen, ... European heart journal 39 (6), 442-449, 2018 | 97 | 2018 |
| Risk of myocardial infarction in anticoagulated patients with atrial fibrillation CJY Lee, TA Gerds, N Carlson, AN Bonde, GH Gislason, M Lamberts, ... Journal of the American College of Cardiology 72 (1), 17-26, 2018 | 70 | 2018 |
| Out-of-hospital cardiac arrest: Probability of bystander defibrillation relative to distance to nearest automated external defibrillator KB Sondergaard, SM Hansen, JL Pallisgaard, TA Gerds, M Wissenberg, ... Resuscitation 124, 138-144, 2018 | 70 | 2018 |
| Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study G Hodges, J Pallisgaard, AMS Olsen, P McGettigan, M Andersen, ... BMJ open 10 (12), e041295, 2020 | 64 | 2020 |
| Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists R Sørensen, B Jamie Nielsen, J Langtved Pallisgaard, C Ji-Young Lee, ... European Heart Journal–Cardiovascular Pharmacotherapy 3 (3), 151-156, 2017 | 53 | 2017 |
| Effectiveness and safety of apixaban versus warfarin as outpatient treatment of venous thromboembolism in US clinical practice D Weycker, X Li, GDV Wygant, T Lee, M Hamilton, X Luo, L Vo, ... Thrombosis and haemostasis 118 (11), 1951-1961, 2018 | 49 | 2018 |
| Combining oral anticoagulants with platelet inhibitors in patients with atrial fibrillation and coronary disease C Sindet-Pedersen, M Lamberts, L Staerk, A Nissen Bonde, JS Berger, ... Journal of the American College of Cardiology 72 (15), 1790-1800, 2018 | 47 | 2018 |
| Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism-A Danish nationwide cohort study C Sindet-Pedersen, JL Pallisgaard, L Staerk, JS Berger, M Lamberts, ... Scientific reports 7 (1), 3347, 2017 | 42 | 2017 |
| Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism C Sindet-Pedersen, JL Pallisgaard, L Staerk, TA Gerds, EL Fosbøl, ... Thrombosis and Haemostasis 117 (06), 1182-1191, 2017 | 41 | 2017 |
| Cardioversion and risk of adverse events with dabigatran versus warfarin—a nationwide cohort study JL Pallisgaard, TB Lindhardt, ML Hansen, AM Schjerning, JB Olesen, ... PLoS One 10 (10), e0141377, 2015 | 40 | 2015 |
| Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study JL Pallisgaard, TB Lindhardt, L Staerk, JB Olesen, C Torp-Pedersen, ... European Heart Journal–Cardiovascular Pharmacotherapy 3 (3), 140-146, 2017 | 37 | 2017 |
| Association between prescribed ibuprofen and severe COVID‐19 infection: a nationwide register‐based cohort study K Kragholm, TA Gerds, E Fosbøl, MP Andersen, M Phelps, JH Butt, ... Clinical and translational science 13 (6), 1103-1107, 2020 | 32 | 2020 |
| GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study F Dalgaard, K Pieper, F Verheugt, AJ Camm, KAA Fox, AK Kakkar, ... Bmj Open 9 (11), e033283, 2019 | 31 | 2019 |
| High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome Á Árnadóttir, KR Vestergaard, J Pallisgaard, G Sölétormos, R Steffensen, ... International Journal of Cardiology 259, 186-191, 2018 | 31 | 2018 |
| Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation PV Rasmussen, F Dalgaard, GH Gislason, A Brandes, SP Johnsen, ... European Heart Journal 43 (7), e38-e44, 2022 | 30 | 2022 |
| Rate or rhythm control in older atrial fibrillation patients: risk of fall‐related injuries and syncope F Dalgaard, JL Pallisgaard, AK Numé, TB Lindhardt, GH Gislason, ... Journal of the American Geriatrics Society 67 (10), 2023-2030, 2019 | 30 | 2019 |
| Management of atrial fibrillation in older patients by morbidity burden: insights from get with the guidelines‐atrial fibrillation F Dalgaard, H Xu, RA Matsouaka, AM Russo, AB Curtis, PV Rasmussen, ... Journal of the American Heart Association 9 (23), e017024, 2020 | 28 | 2020 |
Gunnar GislasonProfessor of Cardiology, Copenhagen University Hospital Herlev and GentofteVerified email at regionh.dk
